• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov10
Alterity Therapeutics Presents Favorable Data on ATH434 for Orthostatic Hypotension and MSA
12:26
Oct14
Jason McCarthy Issues Buy Rating on Alterity Therapeutics Stock
18:56
Sep29
Alterity Therapeutics Predicts ATH434 Global Peak Sales of $2.4 Billion
05:01
Aug29
Alterity Therapeutics released FY2025 earnings on August 28 (EST), actual revenue USD 3.526 M (forecast USD 3.591 M), actual EPS USD -0.7386 (forecast USD -0.82)
03:00
Alterity Therapeutics released FY2025 9 Months Earnings on August 28 (EST), actual revenue USD 2.259 M, actual EPS USD -0.6765
03:00
Alterity Therapeutics released FY2025 Q3 earnings on August 28 (EST), with actual revenue of USD 1.205 M and EPS of USD -0.1252
03:00

Schedules & Filings

Schedules
Filings
Aug28
Earning Release(EST)

FY2025 Q4 Earning Release (USD) Revenue 1.25 M, Net Income -1.623 M, EPS -0.1299

Feb28
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 499.51 K, Net Income -2.231 M, EPS -0.2612

Aug29
Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 706.56 K, Net Income -4.208 M, EPS -0.5262

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More